Director Kush Parmar resigns from Vor Biopharma board before 2023 annual meeting

Vor Biopharma Inc.

Kush Parmar, M.D., Ph.D., resigned effective immediately prior to the 2023 Annual Meeting.
Parmar was one of the longest-tenured directors, joining the Board in February 2019.
He previously served as Board chair (Jan-Jun 2021) and interim CEO (Feb-Aug 2019).
The resignation was not due to any disagreement with the Company.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Kush Parmar, M.D., Ph.D.

member of the Board of Directors

VOR · Vor Biopharma Inc.

Filed: April 14, 2023, 7:59 PM ET

On April 12, 2023, Kush Parmar, M.D., Ph.D., a member of the Board of Directors (the “Board”) of Vor Biopharma Inc. (the “Company”), delivered his notice of resignation to the Board, effective immediately prior to the 2023 Annual Meeting of Stockholders of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Kush Parmar, M.D., Ph.D. resigned as member of the Board of Directors at Vor Biopharma Inc..

Action: resigned
Role: member of the Board of Directors

Exact text from the filing

On April 12, 2023, Kush Parmar, M.D., Ph.D., a member of the Board of Directors (the “Board”) of Vor Biopharma Inc. (the “Company”), delivered his notice of resignation to the Board, effective immediately prior to the 2023 Annual Meeting of Stockholders of the Company.

View on SEC.gov

Vor Biopharma Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-102020

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.